Teladoc Health (TDOC) — Q3 FY2026 Earnings Briefing
Executive Summary
- A transition quarter that beat its own guide: revenue fell 3.4% YoY to $605 million, near the top of the range, while adjusted EBITDA rose 13.5% YoY to $79 million, above the top of guidance.
- The BetterHelp insurance pivot outperformed its yardsticks in the first full quarter under the new playbook, with both insurance revenue and insured-session volume clearing the tops of the ranges management had set.
- The pivot’s second engine is a deliberate cash-pay unwind: advertising was cut hard, an even sharper Q4 step-down is guided, and cash-pay revenue is framed to shrink with it through 2027.
- Integrated Care carried the P&L, over-delivering on margin and modestly raising the full-year outlook, with part of the beat recycled into Q4 growth investments.
- Balance-sheet repair got a playbook of its own: a two-phase plan to repurchase a substantial portion of the June 2027 convertible notes, potentially before year-end, with the remainder repaid in cash at maturity.
Highlights and Lowlights
Highlights
- BetterHelp insurance revenue of $32 million exceeded the high end of management’s expectation range, rising $10 million sequentially as network capacity scaled.
- Weekly insured sessions reached 27,000, an annualized insurance revenue run rate above $140 million versus the $110 million bar referenced at the Q2 call.
- Adjusted EBITDA of $79 million grew 13.5% YoY and beat the top of guidance, with consolidated margin up roughly 200 bps to 13.1%.
- Integrated Care delivered an 18.8% adjusted EBITDA margin, up about 180 bps YoY and well above its guidance range despite visit-based mix pressure.
- Chronic-care enrollment reached 1.34 million members, up 15% YoY and 6% sequentially, while international revenue kept compounding double digits.
- BetterHelp added over 3,000 therapists to the network in the quarter, lifting the credentialed total past 11,000, with capacity metrics trending positively across markets and payers.
- Full-year revenue guidance rose $13 million at the midpoint on the BetterHelp update, with adjusted EBITDA up $3 million and free cash flow narrowed around an unchanged midpoint.
Lowlights
- BetterHelp revenue fell 12.8% YoY to $207 million, with cash-pay declines hitting both U.S. and non-U.S. markets.
- Average paying users slid to 336,000, down 12% YoY and 3% sequentially, as the pivot trades DTC payers for a smaller insurance book.
- BetterHelp’s full-year revenue guide implies a 16.1%–12.9% decline versus 2025, and 2027 cash-pay revenue is framed to fall “generally in a similar corresponding manner” to another mid-to-high-20s% advertising reduction.
- Q4 brings the sharpest advertising pullback yet: management guided a more meaningful sequential cut than prior years’ holiday retrenchment, compounding seasonality in session utilization.
- Integrated Care’s subscription revenue declined even as chronic care and visits grew, capping segment revenue growth at 2.3% YoY.
- The consolidated top line still shrinks at the raised midpoint — 2026 remains a down-revenue year pending 2027 proof.
- The selling season stays fluid, with bookings progressing in line rather than ahead as health plans work through regulatory changes, medical-cost pressure, and their own strategic uncertainty.
1. The BetterHelp Pivot to Insurance
The quarter was the first full one under the actions announced at the Q2 call — a national insurance footprint, an advertising approach retooled around insurance objectives, and reduced near-term emphasis on non-U.S. markets. Management judged the early traction “constructive,” and the numbers support the framing.
Revenue and volume. Insurance revenue of $32 million exceeded the high end of the forward expectation range set on the Q2 call and rose $10 million sequentially. Volume grew alongside it: weekly insurance-covered sessions recently hit 27,000, which management computes to an annualized run rate above $140 million — versus the $110 million annualized rate cited at the Q2 call. The CFO confirmed on the Q&A (“we are going to exit this year at that level as well”) that the same run rate is intended to carry into year-end. One quarter ago this would have been the segment’s whole story; it is now the growth rail beside a shrinking cash-pay book (see Section 2).
Mix and funnel. Insurance is taking share of the acquisition funnel itself: 36% of acquired U.S. users in the quarter came from insurance, up roughly 8 percentage points sequentially. Since the Q2 national-footprint move, marketing has been rebalanced so that “BetterHelp accepts insurance” can be messaged nationally rather than state-by-state, letting demand generation connect to available capacity at lower spend.
Supply. BetterHelp added over 3,000 therapists during the quarter, taking the credentialed network past 11,000 — the largest quarterly addition since the pivot began. Management said capacity-level metrics (therapists active on the platform, those accepting new patients, and coverage on both a market and payer basis) have generally trended positively since Q2. In the Q&A, management disclosed that current payer contracts cover over 150 million lives, framing the runway as activation rather than new contracting — and confirmed the analyst-provided onboarding cadence this quarter exceeded the prior two. Pace is being supported by compensation-model changes tuned to local market conditions to add pay predictability and deepen the share of each therapist’s roster, plus platform work: improved scheduling and matching, streamlined provider workflows, and AI-enabled tools to reduce administrative burden. To widen payer participation, BetterHelp already has delegated credentialing arrangements with a number of plans and is exploring NCQA accreditation for delegated credentialing to qualify for more.
The 2027 commitment. Management laid out directional 2027 goals ahead of formal guidance due on the Q4 call: sequential quarterly insurance growth through 2027 and an annualized insurance revenue run rate of at least $200 million exiting 2027. Both are stage-gated on execution — provider capacity, therapist engagement, and per-session economics the company declined to fix at roughly $100 per insured visit (see the analyst-Q&A breakdown).
2. The Cash-Pay Unwind and the 2027 Ad Math
Cash pay performed better than management anticipated in Q3 — partly on somewhat favorable customer acquisition costs and improvement in a few metrics — but the company’s own posture is that the pressure is structural, not seasonal. The core message, repeated in different forms through prepared remarks and Q&A: “we continue to expect ongoing challenges in cash pay going forward.”
The mechanism. BetterHelp’s advertising and marketing spend fell 27% YoY in the quarter, the first full quarter under the additional pivot actions — and that reduction is treated as a feature, not a cost save. The logic, per the Q&A: historical correlation between advertising levels and cash-pay user acquisition means deliberate spend-downs flow through to acquisition. Q4 takes this further, with a “more meaningful sequential quarterly reduction” than the typical holiday retrenchment, when ad pricing is less efficient. For FY2026 the segment guide assumes a mid-20s% ad-spend decline versus 2025; for 2027 the direction is mid-to-high-20s%, with cash-pay revenue — excluding insurance — expected to move “generally in a similar corresponding manner.”
The user base. Average paying users of 336,000 fell 12% YoY and 3% sequentially — the leading indicator of the erosion the strategy accepts as the price of the pivot. The quarter’s better-than-feared cash-pay performance does not alter the outlook; management was explicit that the pressure continues.
Why the market changed. Management’s framing: the cash-pay model filled a gap when payer network access for mental health was thin and providers were hard to reach; post-pandemic, insurance-side capacity has grown, others have entered in-network models, and consumers with the choice of using a benefit will prefer it — paying out of pocket is, in management’s words, “the equivalent of a car payment.” The residual cash-pay case is intentionally preserved: consumers outside the network, or avoiding insurance use for stigma reasons. Long term, BetterHelp aims to offer both rails in the U.S., with non-U.S. potential over time — but the near-term trajectory is a managed shrink toward the in-network model management calls “more durable.”
3. Integrated Care: Growth Quality and the Margin Drive
Growth composition. Integrated Care revenue of $398 million grew 2.3% YoY and came in above the guidance midpoint. The mix is telling: international grew double digits, chronic care and visits revenue grew, M&A closed within the previous four quarters added a roughly 30 bps tailwind — and subscription revenue declined, the ongoing consequence of the subscription-to-visit revenue model shift. U.S. membership ended at 100.1 million, in the upper half of the guidance range. Chronic-care enrollment reached 1.34 million, up 15% YoY and 6% sequentially, on bundled-solutions adoption and improved member engagement.
Margin. Integrated Care adjusted EBITDA was $75 million, up 13.3% YoY, at an 18.8% margin — up roughly 180 bps YoY and well above the high end of the segment’s guidance range. Two things make this notable: it happened despite the continuing mix shift toward visit-based arrangements (a gross-margin headwind), and it funds real spending — management is recycling part of the beat into “measured incremental investments” in Q4 growth initiatives aimed at 2027.
Operating system. The efficiency gains are compounding: U.S. member self-service interactions were up 30% YoY through AI-enabled digital experiences and related enhancements, and AI-assisted quality assurance plus operational controls are keeping client-configuration and onboarding accuracy high. This is the machinery behind the margin outperformance rather than a one-time cost event.
Q4 bridge. On the Q&A, management said the full-year posture was unchanged despite the beat because Q4 carries offsetting puts and takes: FX pressure from currency moves, a flu season assumed similar to 2025 (the analyst-cited prior-year sequential drag of roughly 110 bps went unchallenged), and a small acquisition now in the segment whose benefit management downplayed as a material driver. Full-year and Q4 targets are tabulated in Section 5.
4. The Innovation Agenda: Teladoc One, Hybrid Care, Solo AI
Teladoc One. Announced in July as a “first-of-its-kind” comprehensive care model — moving beyond condition-specific programs to whole-population detection, engagement, and outcomes, delivered by a multidisciplinary care team with adaptive AI insights from the Pulse intelligence engine. The quarter moved it from announcement to execution: initial launch partners were activated, patients began engaging with the new care model, and broader market availability is set for 2027. Management’s pitch to clients is the value of a connected model versus fragmented point solutions, with demonstrated outcomes. On timing, management expects “some benefit in 2027… building further in 2028,” explicitly tied to selling-cycle lag: 2027 selling for 2028. Fee architecture — outcome-based versus visit-based — was asked about directly and left unanswered (see the analyst-Q&A breakdown).
Hybrid care, now in the U.S. The company’s international hybrid playbook — putting virtual clinical services into physical care settings alongside its technology — has been a solid growth source abroad (Canada, France, and Australia were the cited examples). The U.S. asset so far was technology-only; last week the company closed the acquisition of Teledine Health, which provides virtual clinical services to U.S. hospitals and health systems using Teladoc’s technology. The strategic logic: the same dynamics that drove hybrid care abroad — workforce shortages, capacity constraints, financial pressure, rural access gaps — are increasingly prevalent with U.S. hospitals, and Teledine brings the services layer Teladoc had deliberately not staffed. Management framed it as a 2027 push.
Solo platform AI. Earlier in October, Teladoc introduced AI-powered capabilities inside the Solo platform — contact-free vital-sign measurement and ambient clinical documentation brought directly into clinical workflows — aimed at reducing administrative burden in health-system settings.
Mental-health adjacency. Asked about internal referrals — using Teladoc One and Pulse data to identify behavioral-health needs in Integrated Care populations and warm-hand them to insured BetterHelp — management deferred: Integrated Care already treats mental health holistically, BetterHelp is heads-down on the pivot, and synergies will be explored “down the line.” No timeline, no commitment — but the structural optionality is now on record.
5. Consolidated Financials, Guidance, and the 2027 Debt Wall
Quarter results
| Line item | Q3 2026 | YoY change | vs. guidance |
|---|---|---|---|
| Consolidated revenue | $605M | −3.4% | near high end |
| Consolidated adjusted EBITDA | $79M | +13.5% | above high end |
| Consolidated adjusted EBITDA margin | 13.1% | ~+200 bps | — |
| Net loss per share | $(0.15) | improved from $(0.28) | — |
| Integrated Care revenue | $398M | +2.3% | above midpoint |
| Integrated Care adjusted EBITDA | $75M | +13.3% | margin well above high end |
| Integrated Care adjusted EBITDA margin | 18.8% | ~+180 bps | well above high end |
| BetterHelp revenue | $207M | −12.8% | near high end |
| BetterHelp adjusted EBITDA | $4M | — | margin near high end |
| BetterHelp adjusted EBITDA margin | 2.2% | +55 bps | near high end |
| BetterHelp insurance revenue | $32M | — | exceeded expectation high end |
Per-share beats carried pre-tax drags of $0.49 of intangible amortization, $0.06 of stock-based compensation, and $0.02 of restructuring. Free cash flow was $76 million in the quarter, bringing year-to-date free cash flow to $85 million. Liquidity improved with the quarter’s cash and equivalents at $850 million, up $76 million sequentially, and the net-debt-to-trailing-adjusted-EBITDA ratio fell to 0.5x from 1.0x a year ago.
Full-year 2026 guidance (updated)
| Metric | Updated range | Midpoint change |
|---|---|---|
| Consolidated revenue | $2.39B–$2.44B | +$13M, largely on BetterHelp |
| Consolidated adjusted EBITDA | $277M–$303M | +$3M; ~90 bps margin expansion vs. 2025 |
| Free cash flow | $135M–$165M | narrowed; midpoint unchanged |
| Net loss per share | $(0.95)–$(0.75) | narrowed; modest midpoint improvement |
| Stock-based compensation | <$50M | down more than 35% vs. 2025 |
| Integrated Care revenue growth | +1.1% to +2.1% | midpoint unchanged |
| Integrated Care adjusted EBITDA margin | 16.0%–16.6% | raised ~30 bps; ~115 bps YoY expansion |
| BetterHelp revenue growth | −16.1% to −12.9% | — |
| BetterHelp insurance revenue | $99M–$105M | +~$4M at midpoint |
| BetterHelp adjusted EBITDA margin | 2.7%–4.3% | −~30 bps vs. prior range; −~90 bps YoY |
| BetterHelp advertising spend | down mid-20s% vs. 2025 | — |
Q4 2026 guidance
| Metric | Updated range |
|---|---|
| Consolidated revenue | $569M–$615M |
| Consolidated adjusted EBITDA | $74M–$100M |
| Integrated Care revenue | flat to +3.8% YoY |
| Integrated Care adjusted EBITDA margin | 14.5%–16.8% (adjusted EBITDA dollars ~flat at midpoint) |
| BetterHelp revenue | −31.5% to −18.5% |
| BetterHelp insurance revenue | $32M–$38M |
| BetterHelp adjusted EBITDA margin | 9.2%–15.1% |
The 2027 debt wall — now scheduled, not abstract
Management put a two-phase plan behind the $1.0 billion convertible notes maturing June 2027, subject to market conditions: phase one would repurchase a substantial portion of the outstanding notes using a combination of available cash and proceeds from more traditional debt financing, potentially before year-end 2026; phase two would repay the remaining balance with cash at the June 2027 maturity. Net effect claimed: a meaningfully lower gross debt position after mid-2027. Note the guidance caveat: the free-cash-flow and net-loss-per-share ranges exclude any potential impact from these debt-structure changes.
Conclusion
This was the quarter where the pivot’s two halves finally showed up in the same numbers: the insurance rail is compounding faster than management’s own yardsticks, while the cash-pay book is being reduced by choice — and the guidance raise is a margin story rather than a growth story, funded by Integrated Care productivity and advertising discipline. The balance sheet now has more room for error, and the June 2027 maturity has a dated plan instead of an implied problem. What remains unresolved is the size of the finished company: the insurance book is still a fraction of the revenue it is replacing, cash-pay keeps eroding into 2027 by design, and Teladoc One’s economics are still unpriced. 2027 is the proving year — the insurance exit-rate commitment and the cash-pay decay cadence both have to validate in real prints.
Artifacts and Follow-Ups
Key Artifacts — Highest Priority
- Insurance run-rate trajectory against the exit-2027 commitment. The core pivot promise: weekly insured sessions at 27,000 computing to an annualized run rate above $140 million exiting 2026, sequential quarterly growth targeted through 2027, and an annualized insurance revenue run rate of at least $200 million exiting 2027. Every 2027 print confirms or refutes the staircase.
- The Q4 cash-pay step-down. Management committed to a more meaningful sequential advertising reduction than prior years’ holiday retrenchment, and guided BetterHelp revenue down 31.5% to 18.5% YoY for Q4 — the print versus that range and the disclosed ad-spend level test how deep the managed shrink goes.
- Phase-one debt execution before year-end. The two-phase plan for the $1.0 billion June 2027 converts — a substantial repurchase potentially before year-end 2026 using cash plus traditional debt financing — is a dated, monitorable commitment; a financing or repurchase announcement (or conspicuous silence) by year-end confirms or refutes it.
- Teladoc One monetization signal. Baseline: initial launch partners activated, patients engaging with the care model, broader availability in 2027 with “some benefit in 2027… building further in 2028” and the fee model — outcome-based versus visit-based — still undefined. Watch Q4 bookings commentary and any 2027 Teladoc One revenue framing.
- Integrated Care’s full-year targets versus the Q4 investment drag. Baselines: 1.1%–2.1% FY revenue growth with the midpoint held, 16.0%–16.6% FY margin after a ~30 bps raise, and a Q4 margin guide of 14.5%–16.8% that absorbs the incremental 2027-focused investments funded by the Q3 beat.
Secondary Tracking Items
- Therapist network dynamics: credentialed (past 11,000) and active-therapist counts, and payer-level capacity reads next quarter.
- NCQA accreditation progress for delegated credentialing — the lever for adding payers without bespoke credentialing builds.
- U.S. Integrated Care membership versus the 100.1 million print and its guided band.
- Chronic-care enrollment and international growth rates — the offset engines for the subscription-decay model shift.
- Subscription/PMPM revenue trend and visit-based mix inside Integrated Care.
- Self-service interaction growth and AI-assisted QA/operational metrics as the margin-machinery proof points.
- Any formal BetterHelp 2027 framing beyond the directional insurance and ad-spend script at the Q4 call.